Article 25 Mar 2026 Congress Seeks Answers On Most-Favored-Nation Drug Pricing Agreements And Their Impact On Medicaid United States Healthcare
Article 23 Mar 2026 PBM Reform 2026: What Recent Legislation Means For The Industry (Video) United States Healthcare
Article 13 Feb 2026 What PBMs And Group Health Plans Need To Know About The Department Of Labor's Proposed PBM Fee Disclosure Rule United States Employment
Article 12 Feb 2026 Congress Passes Landmark PBM Reform In 2026 Spending Bill United States Healthcare
Article 28 Jan 2026 Understanding California SB-41: What PBMs Operating In California Need To Know United States Employment
Article 07 Jan 2026 The BALANCE Model And A New Wave Of CMS Drug Pricing Models United States Healthcare
Article 30 Dec 2025 Pharmaceutical Policy In Motion Continued: Trump Inks Nine New Drug Pricing Deals United States Healthcare
Article 30 Dec 2025 CMS Targets Rising Drug Costs With New Guard And Globe Pilot Programs United States Healthcare
Article 19 Nov 2025 Pharmaceutical Policy In Motion: Updates On The Trump Administration's Drug Pricing Initiatives United States Healthcare
Article 13 Nov 2025 CMS Finalizes Key Requirements For Bona Fide Service Fees In CY 2026 Physician Fee Schedule Rule United States Healthcare
Article 21 Oct 2025 Understanding California SB-41: What PBMs Operating In California Need To Know United States Healthcare
Article 09 Oct 2025 A Pivotal Week For Pharmaceutical Policy: Trump Administration Advances Tariff And Drug Pricing Initiatives United States Healthcare
Article 22 Sep 2025 Mintz IRA Update — The Uncertain State Of Affairs For GLP-1s United States Healthcare
Article 22 Sep 2025 Mintz IRA Update — Medicare Part B Physician Fee Schedule Guidance And Its Potential Implications For Medicare Part D United States Healthcare
Article 19 Sep 2025 Mintz IRA Update — Disrupting The Pharmaceutical Supply Chain: The Era Of The DTC Model United States Healthcare
Article 18 Sep 2025 Mintz IRA Update — PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform United States Healthcare
Article 17 Sep 2025 Mintz IRA Update — Under Pressure: The Trump Administration's Drug Pricing Executive Orders United States Healthcare
Article 17 Sep 2025 PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform United States Healthcare
Article 16 Sep 2025 Mintz IRA Update — Still Undefeated: Government Notches Three More Victories In Negotiation Program Lawsuits United States Healthcare
Article 12 Aug 2025 Trump Sends Letters To Manufacturers Regarding Most-Favored-Nation Executive Order Requirements United States Healthcare